Metformin Hydrochlorid Market

Metformin Hydrochlorid is an oral medicine used to treat cardiovascular diseases such as hypertension.

Metformin Hydrochlorid Market contains market size and forecasts of Metformin Hydrochlorid in global, including the following market information:

• Global Metformin Hydrochlorid Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Metformin Hydrochlorid Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Metformin Hydrochlorid companies in 2021 (%)

The global Metformin Hydrochlorid market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

0.25g Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Metformin Hydrochlorid include Merck Group, 1A Pharma GmbH, STADAPHARM GmbH, ALIUD Pharma GmbH, Sumitomo Dainippon Pharma, Fusen Pharmaceutical Company Limited, Chengdu Hengrui Pharmaceutical Co., Ltd., Sihuan Pharmaceutical and Beijing Zhonghui Pharmaceutical Industry, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Metformin Hydrochlorid manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Metformin Hydrochlorid Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Metformin Hydrochlorid Market Segment Percentages, by Type, 2021 (%)

• 0.25g
• 0.5g
• 0.85g

Global Metformin Hydrochlorid Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Metformin Hydrochlorid Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Pharmacy

Global Metformin Hydrochlorid Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Metformin Hydrochlorid Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Metformin Hydrochlorid revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Metformin Hydrochlorid revenues share in global market, 2021 (%)
• Key companies Metformin Hydrochlorid sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Metformin Hydrochlorid sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck Group
• 1A Pharma GmbH
• STADAPHARM GmbH
• ALIUD Pharma GmbH
• Sumitomo Dainippon Pharma
• Fusen Pharmaceutical Company Limited
• Chengdu Hengrui Pharmaceutical Co., Ltd.
• Sihuan Pharmaceutical
• Beijing Zhonghui Pharmaceutical Industry
• Youcare Pharmaceutical Group
• China Associate (Group) Co., LTD
• Shanghai Hengshan PharmaceuticalCoLtd
• Tianan Pharmaceutical
• Shanghai Sine Pharmaceutical Factory
• Beijing Jingfeng Pharmaceutical Group Co., Ltd.
• Hebei Tiancheng Pharmaceutical Co., Ltd
• Shijiazhuang Yiling Pharmaceutical Co Ltd
• Chongqing Conquer Pharmaceutical Co., Ltd.